Expression of RhoC and its regulators RhoGDIbeta, RhoGDIgama and their clinical importance in lung squamous cell cancer and adenocarcinoma
Background and objective It has been proven that RhoC is known to be overexpressed in tumor. The activities of RhoC are negatively regulated by guanine nucleotide dissociation inhibitor beta,gama(GDIbeta,gama), but its role in cancer is quite limited. The purpose of the study is to investigate the e...
Main Authors: | Dongming LIU, Yuexin XU, Zhongyan GUAN, Hongmei DUAN, Enhua WANG, Yuchen HAN |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2008-08-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.04.030&path%5B%5D=122 |
Similar Items
-
Regulation of Rho GTPases by RhoGDIs in Human Cancers
by: Hee Jun Cho, et al.
Published: (2019-09-01) -
Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
by: Adriana E Golding, et al.
Published: (2019-10-01) -
Uncovering the secret life of Rho GTPases
by: Jenna A Perry, et al.
Published: (2019-12-01) -
The Dual Function of RhoGDI2 in Immunity and Cancer
by: Mudrika Tripathi, et al.
Published: (2023-02-01) -
Mechanisms of RhoGDI2 Mediated Lung Cancer Epithelial-Mesenchymal Transition Suppression
by: Huiyan Niu, et al.
Published: (2014-11-01)